Department of Maria Plus IVF Center, Maria Plus Fertility Hospital, Seoul, Republic of Korea.
Division of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
Gynecol Obstet Invest. 2020;85(3):252-258. doi: 10.1159/000507441. Epub 2020 Apr 8.
BACKGROUND/OBJECTIVES: Mechanical micro-vibration remains insufficient for improving embryo culture conditions in human immature oocytes. This study compared the clinical outcomes and embryo development between germinal vesicle (GV) oocytes with the micro-vibration culture (MVC) system in in vitro maturation (IVM) cycles and in vivo-matured oocytes in controlled ovarian hyperstimulation (COH) cycles in polycystic ovarian syndrome (PCOS) patients.
This study investigated 152 PCOS patients who underwent 159 fresh embryo transfer cycles, including IVM cycles with embryos derived from GV oocytes and the COH cycles with embryos derived from in vivo-matured oocytes. The IVM cycles were divided into groups according to the culture system used: static culture (SC) and MVC: In the IVM-S group (n = 47), SC was applied during both IVM and in vitro culture (IVC), whereas in the IVM-MV group (n = 44), MVC was applied during both IVM and IVC. For the COH cycles, in the COH-S group (n = 68), SC was applied during IVC.
The number of in vitro-matured oocytes was similar in the IVM-S and IVM-MV groups, but the good-quality embryo (GQE; ≥6-cells) rate was significantly higher in the IVM-MV group (p < 0.01). The GQE rate and clinical outcomes of the COH-S group were significantly better than those of the IVM-S group (p < 0.05) but similar to those of the IVM-MV group.
Compared with the SC system, the MVC system in IVM cycles improves the embryonic quality of GV oocytes and clinical outcomes, resulting in development of potential equivalent to in vivo-matured oocytes.
背景/目的:机械微振动仍然不足以改善人类未成熟卵母细胞的胚胎培养条件。本研究比较了在多囊卵巢综合征(PCOS)患者的体外成熟(IVM)周期中使用微振动培养(MVC)系统和在控制性卵巢过度刺激(COH)周期中体内成熟卵母细胞的GV 卵母细胞的临床结局和胚胎发育。
本研究调查了 152 名接受 159 个新鲜胚胎移植周期的 PCOS 患者,包括来自 GV 卵母细胞的 IVM 周期和来自体内成熟卵母细胞的 COH 周期。根据使用的培养系统将 IVM 周期分为两组:静态培养(SC)和 MVC:在 IVM-S 组(n=47)中,SC 在 IVM 和体外培养(IVC)期间均适用,而在 IVM-MV 组(n=44)中,MVC 在 IVM 和 IVC 期间均适用。对于 COH 周期,在 COH-S 组(n=68)中,SC 在 IVC 期间适用。
IVM-S 组和 IVM-MV 组的体外成熟卵母细胞数量相似,但 IVM-MV 组的优质胚胎(GQE;≥6 细胞)率显著更高(p<0.01)。COH-S 组的 GQE 率和临床结局明显优于 IVM-S 组(p<0.05),但与 IVM-MV 组相似。
与 SC 系统相比,IVM 周期中的 MVC 系统可提高 GV 卵母细胞的胚胎质量和临床结局,使其发育潜力与体内成熟卵母细胞相当。